Show simple item record

dc.date.accessioned2020
dc.date.available2020
dc.date.issued2020
dc.identifier.govdocPAHO/NMH/NV/COVID-19/20-0029
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52477
dc.description.abstractAppropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health disorders, cancer, and asthma could result in severe disease exacerbation and potentially death.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectHypertensionen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectHeart Diseasesen_US
dc.subjectMental Healthen_US
dc.subjectAsthmaen_US
dc.subjectRisk Factorsen_US
dc.subjectVulnerable Populationsen_US
dc.titleAccess to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemicen_US
dc.typeFact sheetsen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/52582
paho.contributor.departmentNoncommunicable Diseases and Mental Health (NMH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO